Comparison of pre-treatment systemic inflammation indices (systemic immune-inflammation index, systemic inflammation response index, and inflammatory benchmark index) in predicting mortality risk in patients with pancreatic cancer.

Contemp Oncol (Pozn) · 2026 · PMC13137428 · PMID 42089034

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

[ 25 ], IBI was highly significant in both univariate and multivariate analyses of prognostic factors for OS in PC, independent of tumour stage and performance status.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.